Directory Profile

Emily A Barr

Emily A Barr, PhD, RN, CPNP-PC, CNM

Assistant Professor
Department of Research
View Curriculum Vitae

Emily Barr, PhD, RN, CPNP-PC, CNM, assistant pressor of research on the tenure track, joined Cizik School of Nursing at UTHealth Houston in January of 2022. Emily Barr grew up near Rochester, NY and completed her bachelor’s in science in Communication Arts with a focus on scientific writing and a minor in African American studies at Cornell University. After working with infants and young children living with HIV in the early 90’s she obtained her master’s in nursing at Yale University where she specialized in pediatric chronic illness care. She began working as a PNP in pediatric HIV research at the Upstate Medical University in Syracuse, NY in 1997 where she cared for women, children, and youth living with HIV and children with primary immunodeficiency disease. Dr. Barr became a certified nurse midwife through SUNY Stony Brook in 1999 and began leading the perinatal AIDS research program in Syracuse, NY.  She worked on the early pediatric HIV treatment studies through the Pediatric AIDS Clinical Trials Group and later became involved in the International Maternal, Adolescent AIDS Clinical Trials group (IMPAACT), Adolescent Trials Network (ATN), Pediatric HIV/AIDS Cohort Study (PHACS) and the HIV Prevention Trials Network (HPTN). Dr. Barr joined the team at the Children’s Hospital Colorado’s HIV program as a PNP and Midwife in 2001 where she worked on many international HIV studies while continuing to provide care to people living with HIV. Since 2008, Dr. Barr managed and directed the HIV treatment and prevention, childhood vaccine, and the COVID-19 research program. She obtained her PhD from the University of Colorado College of Nursing (2021) where she was a student in the Caring Science track with a concentration in Biobehavioral Sciences.

Highlighted publications:

Rough K, Seage GR 3rd, Williams PL, Hernandez-Diaz S, Huo Y, Chadwick EG, Currier JS, Hoffman RM, Barr E, Shapiro DE, Patel K; PHACS and the IMPAACT P1025 Study Teams. Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine. The New England Journal of Medicine. 2018;378(17):1593-1603. 

Barlow-Mosha L, Angelidou K, Lindsey J, Archary M, Cotton M, Dittmer S, Fairlie L, Kabugho E, Kamthunzi P, Kinikar A, Mbengeranwa T, Msuya L, Sambo P, Patel K, Barr E, Jean-Phillipe P, Violari A, Mofenson L, Palumbo P, Chi BH. Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial. Clinical Infectious Diseases. 2016;63(8):1113-1121.  

Related News Items

World AIDS Day: HIV research gaining momentum at Cizik School of Nursing (Dec 2022)

Grant funds study of telehealth for HIV care transitions (Jun 2022)